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AbstrACt
Objective To identify the risk factors for significant 
depressive symptoms in people with visual impairment in 
England and Wales to provide information on who is most 
at risk and to whom support services could be targeted in 
future.
Design A cross-sectional study using baseline data from 
a pragmatic randomised controlled trial.
setting and participants 990 participants aged 18 or 
over attending 1 of 14 low-vision rehabilitation primary 
care optometry-based clinics in South Wales or two 
hospital clinics in London.
Outcome measure A score of ≥6 on the Geriatric 
Depression Scale-15 was classed as clinically significant 
depressive symptoms.
results In a multivariable logistic regression model, 
significant depressive symptoms were associated with age 
(adjusted OR (AOR)=0.82, 95% CI: 0.66 to 0.90, p<0.001), 
ethnicity (AOR non-white compared with white=1.72, 
95% CI: 1.05 to 2.81, p=0.031), total number of eye 
conditions (AOR for two vs one condition=0.98, 95% CI: 
0.67 to 1.43; three or more vs one condition=0.34, 95% CI: 
0.15 to 0.75, p=0.026), self-reported health (AOR for 
excellent vs poor=0.01, 95% CI: 0.00 to 0.12; very good 
vs poor=0.06, 95% CI: 0.03 to 0.13; good vs poor=0.14, 
95% CI: 0.08 to 0.24; fair vs poor=0.28, 95% CI: 0.18 
to 0.46, p<0.001) and self-reported visual functioning 
(AOR=1.45, 95% CI: 1.31 to 1.61, p<0.001).
Conclusion Younger age, a non-white ethnicity, fewer 
eye conditions and poorer self-reported health and 
visual function are risk factors for significant depressive 
symptoms in this population.
trial registration number ISRCTN46824140; Pre-results.
bACkgrOunD 
Vision impairment impacts on all aspects of 
life and is associated with reduced functional 
ability, falls, social isolation and reduced qual-
ity-of-life.1–3 There is also a growing awareness 
that it has a negative impact on mental health 
status too. Population-based studies provide 
robust evidence of an association between 
vision impairment and depression. Typically 
those with a vision impairment are 2–3 times 
more likely to be depressed.4 5 In Britain, 
for example, a large survey of >13 000 older 
adults found that the prevalence of signifi-
cant depressive symptoms in those with good 
vision living in the community was about 
4.6% while in those with a vision impairment 
(<6/18) it was 13.5%.5 
The prevalence of significant depressive 
symptoms is also high in those accessing 
rehabilitation services. Results from a study 
in Australia found that when screened with 
the two item Patient Health Questionnaire-2, 
37% of patients attending rehabilitation 
clinics or eye care services screened positive 
for depressive symptoms.6 Here in the UK, 
we screened over 1000 patients attending 
low-vision rehabilitation appointments using 
the Geriatric Depression Scale (GDS-15), as 
part of the Depression in Visual Impairment 
Trial (DEPVIT), a randomised controlled 
trial.7 We found that 43% of patients reported 
significant depressive symptoms (score ≥6) 
and, significantly, 74.8% were not receiving 
any treatment for depression.8 This finding 
strengths and limitations of the study
 ► This is the first study of risk factors for depressive 
symptoms in people seeking help for vision impair-
ment in England and Wales.
 ► It benefits from a large sample size (n=990) and a 
high response rate (n=990/1323, 74.8%) which in-
crease the generalisability of the findings.
 ► It examines factors which can be readily assessed 
by practitioners in primary care and general hospi-
tal clinics who come into contact with people with 
vision impairment, enabling them to be alerted to 
those most at risk and in need of signposting to sup-
port services.
 ► However, it excludes some more difficult to measure 
factors, such as vision-specific distress, coping style 
and perceived social support which may also predict 
depression in this population.
 ► The study uses a cross-sectional design, so conclu-
sions about direction of causality cannot be made.
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supports previous reports that people with a vision 
impairment are less likely to have their depression identi-
fied than those with good vision.9–11
Because depression goes underdetected in this patient 
group, there is a need to improve routine screening. 
The National Institute for Health and Care Excellence 
(NICE), in their guidelines on ‘Depression in adults with 
a chronic physical health problem’12 suggest that prac-
titioners working in primary care and general hospital 
clinics should be aware that patients with a chronic phys-
ical health problem, especially those with functional 
impairment, are at a high risk of depression. They recom-
mend being alert to possible depression and asking two 
simple screening questions to detect depression.12 Those 
screening positively should be referred to an appropriate 
professional for assessment, in most cases, the patient’s 
general practitioner (GP). Screening should occur in 
both low-vision-specific settings such as rehabilitation 
clinics, and in primary care and general clinical settings 
such as diabetes or stroke clinics, where vision impair-
ment is prevalent. In busy primary care and general 
clinics, understanding who is most at risk of depression 
among this patient group using easy to determine factors 
may help clinicians to target depression screening and 
signpost patients to supportive services.
Previous cross-sectional studies of patients from outpa-
tient eye clinics and low-vision rehabilitation services have 
identified several risk factors for depression including: 
being female, being relatively younger in age, living alone 
and having lower acceptance of vision loss,13 reporting 
poorer self-reported health and having a history of 
mental health problems,13 14 reporting poorer vision-spe-
cific functioning, higher levels of vision-specific distress, 
having an avoidant coping style and lower perceived 
adequacy of social support.14 A longitudinal prospective 
cohort study of 540 patients from outpatient low-vision 
organisations in the Netherlands and Belgium found that 
people who developed depressive symptoms over a 2-year 
period were more likely to be: living alone, having just 
enough money to cover their expenses, have macular 
degeneration, have problems with adaptation to vision 
loss, have reduced health related quality of life and be 
experiencing symptoms of anxiety.15
The above studies were conducted in the Netherlands, 
Belgium and Australia, and we do not know if the same 
risk factors apply to a British population. Therefore, it is 
useful to examine the risk factors for depressive symp-
toms in people with sight loss in England and Wales, 
using a large sample of consecutive attendees to services. 
The findings will enable clinicians in primary care and 
general hospital clinics to allocate resources to screening 
those most at risk.
The aim of this study was to identify the risk factors 
for significant depressive symptoms in people with 
vision impairment attending rehabilitation clinics 
in England and Wales using baseline data from a 
randomised controlled trial of interventions for depres-
sion (DEPVIT).7 We focused our examination mainly on 
characteristics which can be easily identified in routine 
practice, for example, age and ethnicity, to provide a 
straightforward approach to identifying high-risk patients 
based on readily available information.
MethODs
study design and participants
This cross-sectional study was undertaken as part of 
DEPVIT.7 Eligible participants were consecutive adult 
patients who were seeking help for vision impairment 
at specialist visual rehabilitation services taking part in 
DEPVIT. Fourteen primary care-based rehabilitation 
services recruited participants in South Wales. Services 
were readily accessible high street practices, accepted 
self-referral and tended to cater to older adults with 
age-related eye conditions living in the local commu-
nity. A secondary care rehabilitation clinic based at Guys 
and St Thomas’ Hospital and a National Health Service 
(NHS) outreach clinic providing low-vision services in 
Southwark recruited participants from the London area. 
Access to these two specialist clinics was by referral only. 
All consecutive attendees aged 18 or over were consid-
ered eligible for the study, unless they lived outside the 
catchment area for the trial or if they had previously been 
screened for depression as part of the study (some people 
had more than one appointment during the length of the 
study, but we only wanted to screen them and invite them 
to take part once). The study adhered to the Declaration 
of Helsinki.
Funding and public and Patient involvement
The study was funded by Guide Dogs, a voluntary sector 
organisation who work closely with people with vision 
impairment and understand their experiences and pref-
erences. They carried out a review prior to funding to 
ensure the research questions were relevant and the study 
design appropriate. Patients with a vision impairment 
reviewed and provided feedback on the depression ques-
tionnaire. Patients were not involved in the recruitment 
to or conduct of the study.
Measures
Depression
GDS-1516 is one of the most widely used instruments for 
the screening of depression in older adults. The ques-
tionnaire has 15 questions, and the completion time is 
approximately 5 min. Possible scores range from 0 to 15, 
with higher scores indicating a greater number of depres-
sive symptoms. We chose to use dichotomous categories 
rather than the continuous scale as this reflects the scale’s 
use in clinical practice as a screening tool to identify those 
who warrant further investigation. We used the conven-
tional scoring approach rather than Rasch analysis to 
facilitate direct comparison with published studies and to 
facilitate clinically valid results. A score of 6 or more was 
taken to be indicative of significant depressive symptoms.5
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Risk factors
We recorded gender, age, ethnicity (white, Asian/Asian 
British, black/black British or other), physical illness 
(number and type from a list of seven plus an ‘other’ 
category) and ocular diagnosis (number and type of eye 
conditions from a list of five plus an ‘other’ category), 
factors which would be readily available to clinicians 
working with people with sight loss and have been consid-
ered in previous studies.
We also measured self-reported general health as this 
has consistently been shown to be a risk factor for depres-
sion6 13–15 and can be easily measured using a single item 
question from the SF-12, ‘In general, would you say your 
overall health is: excellent, very good, good, fair or poor?’ 
The question has had widespread use as a single-item 
measure, including in previous studies of visual impair-
ment and depression5 14 and has shown to be significantly 
and independently associated with specific health prob-
lems, use of health services, changes in functional status, 
recovery from episodes of ill health, mortality and socio-
demographic characteristics of respondents.17
To provide information on vision related factors for 
low-vision practitioners who have access to this informa-
tion, we also measured presenting corrected binocular 
visual acuity using Early Treatment Diabetic Retinopathy 
Study (ETDRS) LogMAR and recorded time since vision 
loss in years. As previous studies have found no evidence 
of an association between objective measures of visual 
acuity and depression,13–15 we were interested to see 
whether a subjective measure of visual function would be 
associated. Self-reported visual functioning was measured 
using the 7-item National Eye Institute Visual Function 
Questionnaire (NEI-VFQ 7) which includes a subset of 
questions from the NEI-VFQ that have previously been 
shown to be responsive to rehabilitation service interven-
tion.18 As the NEI-VFQ 7 is commonly reported in the 
published literature with Rasch analysis, we transformed 
the Likert responses using the Rasch derived scoring 
key provided by Ryan et al18 to calculate a score for each 
completed questionnaire. A higher score indicates a 
greater perceived difficulty with visual functioning. Ques-
tionnaires with three or more missing items were counted 
as missing and excluded from the analysis.
Procedures
Participants who were eligible to take part in the study 
were sent a questionnaire in large print format containing 
the GDS-15, NEI-VFQ 7 and single-item question about 
health, along with their appointment letter at least 1 week 
before their low-vision assessment. They were asked to 
complete the questionnaire at home, with assistance if 
needed, and to bring it along to their appointment. Those 
who did not return a completed questionnaire were given 
the opportunity to complete another copy at the clinic, 
before their appointment. The low-vision practitioner 
reviewed the participant’s responses with them at the start 
of the assessment and asked for their written consent to 
use their anonymised responses in the study. For those 
who consented, information on gender, date of birth, 
ethnicity, physical illness, ocular diagnosis, corrected 
ETDRS LogMAR acuity and time since vision loss first 
identified were recorded on a Case Report Form (CRF). 
Those who screened positive for depressive symptoms 
(GDS-15 score of ≥6) were offered entry to the DEPVIT 
trial if eligible, or a referral to their GP if not eligible.19
CRFs completed by the clinicians were sent to the 
research coordinating centre at Cardiff University by 
secure fax where the validity and completeness of the 
data were checked. Any missing or out of range data were 
queried with the practitioner and checked with clinical 
notes. Five per cent of all CRFs and surveys were double 
entered. The error rate was less than 2% and identified 
errors were corrected. The number of eligible patients 
who did not complete the survey and the number who 
did not consent for their data to be used for research 
purposes were also recorded. The final dataset was then 
locked and transferred to the statistical team for anal-
ysis. The descriptive statistics were tabulated using SPSS 
V.23, and the regression models were fitted using STATA 
V.13.1.
statistical analysis
Participant characteristics were summarised for those 
with significant depressive symptoms (GDS-15 ≥6) and 
those without (GDS-15 <6). Categorical variables were 
summarised as numbers and percentages and continuous 
variables as medians with interquartile ranges. In all cases 
we report the number of participants for whom data were 
missing.
Where the GDS-15 was not fully completed, completed 
answers were totalled to give a final score provided 
that the number of questions not answered was two or 
less.5 If three or more questions were unanswered, the 
GDS-15 data were regarded as missing and the participant 
excluded from the analysis.
Logistic regression was used to determine the inde-
pendent relationship between each of the potential 
risk factors and significant depressive symptoms. The 
potential risk factors were initially included individually 
(univariable analysis) and then entered into a multivari-
able logistic regression analyses in blocks to determine 
which variables remain associated with significant depres-
sive symptoms after controlling for the other factors. The 
events-per-variable was sufficient to allow inclusion of 
all potential risk factors, so no selection was required.20 
However, due to co-linearity, it was not possible to include 
both number and type of physical illnesses or both 
number and type of eye conditions. Therefore, a decision 
was made to include only number of illnesses and eye 
conditions, as it was hypothesised that burden of multiple 
diagnoses would be more important than type of diag-
nosis: those with multiple morbidity are at twice the risk of 
depression than those without multiple morbidity.21 The 
variables were entered into the analysis in blocks, starting 
with the risk factors which could be most easily identified 
in routine clinics, and ending with those requiring more 
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time or adaptation to practice to assess. The blocks were: 
(1) demographics (gender/age/ethnicity); (2) demo-
graphics and physical health (number of illnesses); (3) 
demographics, physical health and eye health (number 
of eye conditions/visual acuity/time since vision loss); 
(4) demographics, physical health, eye health and self-re-
port measures (self-report health/visual functioning). We 
calculated the area under the Receiver Operating Char-
acteristic (ROC) curve to quantify the overall ability of 
each (additional) block of variables to correctly discrimi-
nate between those with and without depression.
results
A total of 1323 consecutive adult patients attended the 
low-vision rehabilitation clinics during the 30 month 
recruitment period. Of these, 312 were not screened 
for depression because the practitioner felt it was inap-
propriate at the time (because the patient was too ill, 
had dementia or was recently bereaved); or the patient 
had forgotten to complete the questionnaire and there 
was no time at the assessment; or they did not consent 
for their data to be used for research. An additional 21 
patients had three or more missing items on the GDS-15 
and were excluded, leaving a final sample size of 990 and 
a complete response rate of 74.8%. The median age of 
the participants was 79.0 years (IQR=66.0–85.0), 62.2% 
were female (n=616) and 85% were white (n=842). The 
overall prevalence of significant depressive symptoms 
was 42.5%. This varies very slightly from our previously 
reported study (43%)8 due to the methodology used in 
this study to calculate the total GDS-15 score (excluding 
those with ≥3 missing items).
Tables 1–4 outline the demographic characteris-
tics of the participants, their physical health measures, 
eye health measures and self-report health and vision 
measures respectively, split by those with and without 
significant depressive symptoms. They also summarise 
the results of the univariable logistic regression using 
ORs presented with 95% CIs and p values. The variables 
ethnicity, number of physical illnesses and number of eye 
conditions had a small number of participants in some 
categories, hence the categories were collapsed before 
being entered into the regression analysis. Both the 
original and collapsed categories are presented in the 
tables. Table 5 Summarises the results of the multivari-
able logistic regression using adjusted ORs (AOR) and 
are presented with 95% CIs and p values.
Demographics
Table 1 shows that those with a higher prevalence of 
significant depressive symptoms were male, younger or 
non-white. In the univariable analysis, age and ethnicity 
were associated with significant depressive symptoms. An 
increase in age was associated with lower odds of partic-
ipants having depression and having ethnicity other 
than white was associated with higher odds of having 
depression. These variables remain associated once other 
variables were controlled for in the multivariable anal-
ysis final model (table 5). There was no evidence of an 
association between gender and significant depressive 
symptoms.
Physical health
The prevalence of depression was lowest in those with no 
physical illness (29.8%) and highest in those with three 
or more illnesses (54.3%, table 2). In the univariable 
analysis, an increase in the number of physical illnesses 
was associated with higher odds of having significant 
depressive symptoms. This association remained when 
controlling for demographics and eye health but was no 
longer associated when controlling for subjective health 
and visual function.
eye health
Those with a higher prevalence of depression had one eye 
condition, worse visual acuity or less time since vision loss 
(table 3). The univariable analysis found no evidence of 
an association between significant depressive symptoms 
and number of eye conditions, visual acuity and time 
since vision loss. However, when controlling for other 
factors in the final model, an increase in the number of 
eye conditions was associated with lower odds of having 
significant depressive symptoms.
self-report measures
The prevalence of depression was highest in those with 
poor self-rated health (81.5%) and lowest in those with 
excellent health (4.3%). Those with significant depres-
sive symptoms had worse self-rated visual functioning 
(table 4). Worse self-rated health and visual functioning 
were associated with higher odds of having significant 
depressive symptoms in both the univariable analysis and 
multivariable final model.
The area under the ROC curve was 0.59 when demo-
graphics alone were entered into the model, increasing to 
0.65 when physical and eye health variables were consid-
ered and reaching 0.81 when self-report measures were 
added.
DisCussiOn
This study identified the risk factors for significant 
depressive symptoms in people with vision impairment 
attending vision rehabilitation clinics in England and 
Wales. We focused mainly on risk factors which can be 
easily identified in primary care and general hospital 
clinics, so as to provide a pragmatic approach to identi-
fying high risk patients. To inform ophthalmic clinicians 
who may have access to more detailed information on 
eye health, we also included a range of vision related 
variables. Our findings showed that among older adults, 
those of relatively younger age, with an ethnicity other 
than white and poorer self-reported health and visual 
function had higher odds of having significant depres-
sive symptoms. Number of physical illnesses was an 
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independent predictor of depressive symptoms, but there 
was no evidence of an association when controlling for 
subjective health and vision function. The number of eye 
conditions was not an independent predictor of depres-
sive symptoms, but was related to depression when other 
variables were controlled: less number of eye conditions 
was associated with higher odds. There was no evidence 
that gender, time since vision loss and visual acuity were 
associated with depression.
With regard to demographic factors, our findings 
demonstrate some support for, and discrepancies with, 
previous studies. In a study with an Australian popu-
lation,14 a univariate analysis provided evidence that 
younger age was associated with depressive symptoms, 
and in a European and Australian sample (relatively) 
younger age was shown to be associated with subthreshold 
depression in a multivariable analysis.13 Our study corrob-
orates these findings in a UK sample. This perhaps 
reflects the finding in the general population that people 
aged 40–59 years have higher rates of depression than 
those aged ≥60 years22 and those in middle-age have the 
highest risk.23 The reasons for this are not clearly under-
stood, but one theory is that by mid-life, individuals have 
learnt to adapt to their strengths and weaknesses, and in 
mid-life ‘quell their infeasible aspirations’.23 In those with 
vision loss, being affected in middle-age rather than old 
age may add to this sense of lost aspirations and could 
also result in more restriction in life including difficul-
ties in finding and staying in work, playing sport and so 
on. Our research found no evidence of an association 
between gender and depressive symptoms. Previous 
studies examining this association have differed in their 
findings. An Australian study showed no association in a 
univariate analysis,14 while a model with a European and 
Australian sample found being female was a predictor of 
subthreshold depression.13 The authors of a study with 
Table 2 Summary of the physical health of those with and without significant depressive symptoms
Physical health
GDS-15 
score <6
GDS-15 
score ≥6 Total
Univariable logistic regression analysis
N OR 95% CI P value
Physical illnesses*, n (%) Not entered into regression analysis†
  Diabetes 119 (47.8) 130 (52.2) 249
  Epilepsy 8 (57.1) 6 (42.9) 14
  Stroke 31 (50.8) 30 (49.2) 61
  Thyroid 27 (47.4) 30 (52.6) 57
  Heart disease 94 (50.3) 93 (49.7) 187
  High blood pressure 246 (55.5) 197 (44.5) 443
  Respiratory disease 48 (59.3) 33 (40.7) 81
  Other 113 (48.9) 118 (51.1) 231
  No medical illness 113 (70.2) 48 (29.8) 161
  Data missing 4 (100) 0 (0) 4
Total number of physical illnesses, n (%) Not entered into regression analysis‡
  0 113 (70.2) 48 (29.8) 161
  1 277 (60.6) 180 (39.4) 457
  2 127 (48.3) 136 (51.7) 263
  3 41 (47.7) 45 (52.3) 86
  4 4 (28.6) 10 (71.4) 14
  5 2 (50) 2 (50) 4
  6 1 (100) 0 (0) 1
  Data missing 4 (100) 0 (0) 4
Total number of physical illnesses (collapsed 
categories), n (%)
<0.001
  0§ 113 (70.2) 48 (29.8) 161
  1 277 (60.6) 180 (39.4) 457 1.53 1.04 to 2.25
  2 127 (48.3) 136 (51.7) 263 986 2.52 1.66 to 3.82
  3  or more 48 (45.7) 57 (54.3) 105 2.8 1.68 to 4.66
  Data missing 4 (100) 0 (0) 4
*Participants may have had more than one physical illness.
†Not entered due to high correlation with number of physical illnesses.
‡Collapsed categories entered instead.
§Reference category.
GDS, Geriatric Depression Scale.
 o
n
 21 February 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026163 on 17 January 2019. Downloaded from 
7Nollett C, et al. BMJ Open 2019;9:e026163. doi:10.1136/bmjopen-2018-026163
Open access
Ta
b
le
 3
 
S
um
m
ar
y 
of
 t
he
 e
ye
 h
ea
lth
 o
f t
ho
se
 w
ith
 a
nd
 w
ith
ou
t 
si
gn
ifi
ca
nt
 d
ep
re
ss
iv
e 
sy
m
p
to
m
s
E
ye
 h
ea
lt
h
G
D
S
-1
5
sc
o
re
 <
6 
G
D
S
-1
5
sc
o
re
 ≥
6 
To
ta
l
U
ni
va
ri
ab
le
 lo
g
is
ti
c 
re
g
re
ss
io
n 
an
al
ys
is
N
O
R
95
%
 C
I
P
 v
al
ue
O
cu
la
r 
d
ia
gn
os
is
,*
 n
 (%
)
N
ot
 e
nt
er
ed
 in
to
 r
eg
re
ss
io
n 
an
al
ys
is
†
 
 A
M
D
 w
et
11
7 
(5
9.
4)
80
 (4
0.
6)
19
7
 
 A
M
D
 d
ry
25
9 
(6
4.
6)
14
2 
(3
5.
4)
40
1
 
 G
la
uc
om
a
10
4 
(6
3.
0)
61
 (3
7)
16
5
 
 C
at
ar
ac
t
95
 (7
0.
4)
40
 (2
9.
6)
13
5
 
 D
ia
b
et
ic
 e
ye
 d
is
ea
se
59
 (4
8.
0)
64
 (5
2.
0)
12
3
 
 O
th
er
 e
ye
 c
on
d
iti
on
15
7 
(4
7.
9)
17
1 
(5
2.
1)
32
8
 
 D
at
a 
m
is
si
ng
1 
(5
0)
1 
(5
0)
2
To
ta
l n
um
b
er
 o
f e
ye
 c
on
d
iti
on
s,
 n
 (%
) 
N
ot
 e
nt
er
ed
 in
to
 r
eg
re
ss
io
n 
an
al
ys
is
‡
 
 1
38
1 
(5
6)
29
9 
(4
4.
0)
68
0
 
 2
15
3 
(5
8.
8)
10
7 
(4
1.
2)
26
0
 
 3
32
 (7
2.
7)
12
 (2
7.
3)
44
 
 4
2 
(6
6.
7)
1 
(3
3.
3)
3
 
 5
0 
(0
)
1 
(1
00
)
1
 
 D
at
a 
m
is
si
ng
1 
(5
0)
1 
(5
0)
2
To
ta
l n
um
b
er
 o
f e
ye
 c
on
d
iti
on
s 
(c
ol
la
p
se
d
), 
n 
(%
) 
 
 1§
38
1 
(5
6.
0)
29
9 
(4
4.
0)
68
0
 
 2
15
3 
(5
8.
8)
10
7 
(4
1.
2)
26
0
98
8
0.
89
0.
67
 t
o 
1.
19
0.
12
3
 
 3 
or
 m
or
e
34
 (7
0.
8)
14
 (2
9.
2)
48
0.
52
0.
28
 t
o 
1.
00
 
 D
at
a 
m
is
si
ng
1 
(5
0)
1 
(5
0)
2
C
or
re
ct
ed
 b
in
oc
ul
ar
 v
is
ua
l a
cu
ity
 (L
og
M
ar
), 
m
ed
ia
n 
(IQ
R
) 
0.
60
 (0
.4
0,
 
0.
94
)
0.
70
 (0
.5
0,
 1
.0
0)
0.
67
 (0
.4
0,
 1
.0
)
99
0
1.
01
0.
99
 t
o 
1.
03
0.
56
8
D
at
a 
m
is
si
ng
, n
 (%
)
0
0
0
Ye
ar
s 
si
nc
e 
vi
si
on
 lo
ss
, m
ed
ia
n 
(IQ
R
) 
5.
5 
(2
.2
, 1
2.
0)
5.
0 
(2
.1
, 1
0.
2)
5.
2 
(2
.2
, 1
1.
1)
 
97
4
0.
99
0.
99
 t
o 
1.
01
0.
81
8
D
at
a 
m
is
si
ng
, n
 (%
)
13
 (8
1.
25
)
3 
(1
8.
75
)
16
*A
ll 
oc
ul
ar
 d
ia
gn
os
es
—
p
ar
tic
ip
an
ts
 m
ay
 h
av
e 
ha
d
 m
or
e 
th
an
 o
ne
.
†N
ot
 e
nt
er
ed
 d
ue
 t
o 
hi
gh
 c
or
re
la
tio
n 
w
ith
 n
um
b
er
 o
f e
ye
 c
on
d
iti
on
s.
‡C
ol
la
p
se
d
 c
at
eg
or
ie
s 
en
te
re
d
 in
st
ea
d
.
§R
ef
er
en
ce
 c
at
eg
or
y.
A
M
D
, A
ge
-r
el
at
ed
 M
ac
ul
ar
 D
eg
en
er
at
io
n;
 G
D
S
, G
er
ia
tr
ic
 D
ep
re
ss
io
n 
S
ca
le
.
 o
n
 21 February 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026163 on 17 January 2019. Downloaded from 
8 Nollett C, et al. BMJ Open 2019;9:e026163. doi:10.1136/bmjopen-2018-026163
Open access 
Dutch and Belgian participants reported that their find-
ings on gender were inconclusive.15 Differences in find-
ings across the studies may indicate this factor is country 
specific, or may be due to differences in the measures 
used to assess depression. For example, we included 
people with all levels of depressive symptoms, whereas the 
European/Australian study included only subthreshold 
depression. It may be that being female is associated with 
subthreshold depression but there is no association when 
all levels of severity are considered. We found that having 
an ethnicity other than white was a risk factor. Recent 
studies on vision impairment and depression have not 
measured ethnicity, however an earlier study conducted 
in New Zealand found that ethnicity was not related to 
depression.24 Differences between that study and ours 
may be due to the different populations, with a wider 
variation in ethnicities in the UK and London in partic-
ular. The New Zealand study only recorded ‘New Zealand 
born European’ or ‘other’. Therefore, future studies 
should include ethnicity as a variable to provide further 
clarification.
There is more consistency between European and 
Australasian studies and our UK study in terms of health. 
We demonstrated that those with poorer self-reported 
health were at much higher risk of depressive symptoms. 
This confirms previous research in vision-impaired people 
which has shown that poorer perceived health status,13 
poorer self-reported health14 and poorer health related 
quality of life24 are all predictors of depression. This is 
not surprising as patients may include their emotional 
health in a question about general health. Our study also 
found that a higher number of physical illnesses was an 
independent risk factor for depression. This is in line 
with findings from the non-vision-impaired population. 
A recent meta-analysis found a substantial relationship 
between multimorbidity (the presence of two or more 
chronic physical illnesses) and depression, reporting 
that people with multimorbidity are at twice the risk of 
depression to those without multimorbidity, and nearly 
three times at risk compared with those with no chronic 
physical condition.21 The authors suggest the relationship 
is bidirectional and cite the Activity Restriction Model of 
Depressed Affect25 which explains that multimorbidity 
contributes significantly to depressive symptoms through 
having to give up valued activities due to physical limita-
tions. In our sample, the limitations of conditions such as 
stroke and diabetes may have compounded any mobility 
and functional issues already caused by sight loss which 
can make self-care, engaging in hobbies and getting out 
and about more difficult.
In terms of vision related factors, it is logical to assume 
that the chances of having depressive symptoms increases 
as visual acuity decreases. However, in line with other Euro-
pean and Australian studies,13–15 the results of the regres-
sion analysis do not support this hypothesis. What seems 
to be more important is self-reported visual function: 
those with worse self-reported visual function are more 
at risk of depressive symptoms.26 Therefore, clinicians 
should take care not to make assumptions about the like-
lihood of depression in only those with the lowest levels of 
vision as assessed by visual acuity. The relationship is likely 
to be bidirectional, with poorer visual function leading to 
loss of valued activities and mood, while lowered mood 
may influence a person’s perception of their vision func-
tion. As with previous studies,13 15 time since the vision 
loss was first identified was also not a predictor of depres-
sion, indicating that patients may develop symptoms at 
any point on their sight loss journey. The more surprising 
finding was that people with three or more eye conditions 
had lower odds of having significant depressive symptoms 
than those with just one eye condition. On consulta-
tion with the literature, we suggest this finding may be 
explained in terms of acceptance: lower acceptance of 
vision loss has shown to be a predictor of subthreshold 
depression.13 In their work with people with diabetic eye 
disease and partial sight loss (some of whom also had 
glaucoma), Oehler-Giarratana and Fitzgerald report that 
patients described being in a state of ‘limbo’ where they 
Table 4 Summary of the self-reported health and visual function of those with and without significant depressive symptoms
Self-report measures
GDS-15
score <6 
GDS-15
score ≥6 Total
Univariable logistic regression analysis
N OR 95% CI P value
Self-rated health (SF-12), n (%) <0.001
  Excellent 22 (95.7) 1 (4.3) 23 0.01 0.00 to 0.08
  Very good 93 (86.1) 15 (13.9) 108 0.04 0.02 to 0.07
  Good 201 (72.6) 76 (27.4) 277 952 0.09 0.05 to 0.14
  Fair 192 (52.5) 174 (47.5) 366 0.21 0.13 to 0.32
  Poor* 33 (18.5) 145 (81.5) 178
  Data missing 28 (73.7) 10 (26.3) 38
Visual functioning† 0.23 (-1.43, 1.46) 1.41 (0.17, 2.49) 0.78 956 1.48 1.36 to 1.60 <0.001
(NEI VFQ-7), median (IQR) 23 (67.6%) 11 (32.4%) (−0.80, 1.91)
Data missing n (%) 34
*Reference category.
†NEI VFQ-7 scores have been Rasch analysed and a higher score indicates a greater perceived difficulty with visual functioning.
GDS, Geriatric Depression Scale; NEI VFQ-7, 7-item National Eye Institute Visual Function Questionnaire.
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experienced uncertainty, fear and hope that vision might 
improve.27 Perhaps surprisingly, they expressed the view 
that total loss of vision would be a relief, as they could 
proceed through a healing phase and make plans for 
their future care. In our study, it is possible that those with 
three or more eye conditions had come to terms with the 
likelihood of further vision loss and reached a point of 
acceptance, whereas those with one eye condition were in 
the ‘limbo’ phase, with the hope that sight may improve 
but the fear that it might deteriorate, and therefore not 
reached this point of acceptance thus increasing their 
risk of depressive symptoms. None of the studies referred 
to in our introduction included number of eye condi-
tions as a risk factor, and we could not find any studies 
which included both number of eye conditions and level 
of acceptance. Therefore, further research is needed to 
better understand this finding and possible explanation. 
Our research suggests that not all of the factors related 
to depressive symptoms in people with vision impairment 
are specific to that particular population. As with the 
general population, age, ethnicity and health are associ-
ated with risk of depression and this needs to be taken 
into consideration when understanding the link between 
vision impairment and depression, and when considering 
suitable interventions.
This research added to the literature by examining risk 
factors in a British sample of people with vision impair-
ment. The study benefited from a large sample size and 
a high response rate, enhancing the generalisability of 
the findings. As we included 14 low-vision rehabilitation 
clinics across primary and secondary care, we believe the 
findings are transferrable to both settings in the UK. Our 
study employed validated measures of depressive symp-
toms and incorporated risk factors which are easy to 
identify in primary care and hospital clinics. Therefore, 
the results can be easily integrated in clinical practice to 
target screening.
However, inevitably there were some value judge-
ments in how we chose our criteria for selecting the 
range of potential factors in our study. This means that 
other parameters which have previously been shown to 
be predictors of depression, for example, vision-specific 
distress, lower perceived adequacy of social support and 
avoidant coping,14 were not measured and therefore 
cannot be included in the risk profile advice to clini-
cians. These parameters can only be assessed using addi-
tional questionnaires which would have increased the 
overall response burden in the study, and furthermore, 
it is unlikely that these variables would be measured in 
routine practice and therefore were not within the scope 
of our study.
We chose to dichotomise the GDS-15 to reflect how it 
would be used in practice, as a screening tool for identi-
fying patients who would benefit from screening in clinic 
and potentially signposting to support services. However, 
we acknowledge that this may have led to a reduction 
in power and loss of information.28 A further limitation 
of the study is the use of a cross-sectional design which 
means conclusions about direction of causality are not 
possible. Finally, while the completion rate of the GDS-15 
was high, a number of patients were not screened at the 
discretion of the practitioners, including because they felt 
the patient was too ill, had dementia or had recently been 
bereaved, or they did not consent for their answers be 
used for research. Therefore, there may be a risk of bias as 
the non-completers may be systematically different from 
those that completed the questionnaire and consented 
to their data being used. Similarly, we excluded cases 
with missing data from the multivariable analysis and 
this simple approach to missing data may have intro-
duced some bias. However, as only 113/990 (11%) were 
excluded, the risk of bias was low.
For the first time, for a population in England and 
Wales, our study demonstrates that for patients with vision 
impairment, there are several risk factors for depression 
which can be easily identified by those coming in to 
contact with people with sight loss. We recommend that 
all clinicians working with people with sight loss are alert 
to these factors. We advise screening higher risk patients 
using the simple two question screen recommended in 
the NICE guidelines.12 If a patient is identified as having 
likely depression, they should be managed according to 
the guidelines which includes referral to an appropriate 
professional, for example, the GP. Local pathways should 
be established to manage this referral. However, because 
the prevalence of depressive symptoms is so high in low-vi-
sion clinics, we recommend that low-vision practitioners 
introduce depression screening as part of routine care 
with all patients.
Future research could include qualitative work to clarify 
the pathway from the risk factors identified here to the 
onset of depression, to aid the development of interven-
tions for depression in this population.
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